Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MedCAC meeting for CPAP

This article was originally published in The Gray Sheet

Executive Summary

The Medicare Evidence Development and Coverage Advisory Committee will convene Sept. 12 to discuss obstructive sleep apnea diagnosis requirements to qualify patients for coverage of continuous positive airway pressure therapy. CMS decided in March to reconsider its national coverage policy disallowing home-based sleep testing (1"The Gray Sheet" March 19, 2007, p. 12). The meeting pushes back CMS' decision timeline; a proposal is now expected Dec. 14, to be finalized in March...

You may also be interested in...

CMS May Relax Sleep Apnea Testing Requirement For CPAP Coverage

CMS will reconsider how it pays for continuous positive airway pressure (CPAP) therapy, potentially modifying diagnosis requirements to help expand therapy coverage to more patients with sleep apnea

EWG Study Suggests More Than One In 10 Talc-Based Cosmetics Contain Asbestos

The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.

Atlas Biomed Unlocking Japan’s OTC Market With Direct-To-Consumer DNA And Microbiome Tests

Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus. 




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts